account"Avid Radiopharmaceuticals Inc., an eight-year-old startup, will likely beat General Electric Co. and Bayer AG to the market with the first imaging test to pinpoint Alzheimer’s early on in the disease,"- According to Bloomberg's Elizabeth Lopatto and Kanoko Matsuyama.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to GE, Bayer Loom Over Avid's Lead in Creating Alzheimer's Test - Bloomberg
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account